RxDoctor Payments Data

Christopher Roxbury, MD

Otolaryngology · Cleveland, OHNPI 1497012694

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,350 of the $5,270 with a category attached, or 82.5%. 16 manufacturers reported payments, led by Stryker at 27.0% of the total. 2025 is the largest year on record at $1,659, 3.9 times the $429 reported in 2019.

$5,270in general payments, 2019–2025

Across 50 payments — averaging $105.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Acclarent, Inc$1K
  • Medtronic$710
  • Integra Lifesciences Corporation$329
  • Neurent Medical Limited$208
  • GSK$195
  • plus $1K from 10 others
$2,000in research payments, 2019–2025

Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$2K

What the payments were for

  • Consulting fees$92017%
  • Food & beverage$4,35083%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,270 in reported general payments places this provider in the 85th percentile of 380 otolaryngology providers in Ohio.

See all otolaryngology providers in Ohio

Medicare billing

Part B allowed, 2024
$46,857
Medicare patients
133
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl73$1,932
Ipratropium Bromide72$1,213
Fluticasone Propionate52$514
Mupirocin47$366
Famotidine31$231
Doxycycline Hyclate15$160

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →